2024
DOI: 10.1080/1744666x.2024.2326626
|View full text |Cite
|
Sign up to set email alerts
|

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma

Shabana Habib,
Gabriel Osborn,
Zena Willsmore
et al.

Abstract: Introduction Despite the success of immunotherapies for melanoma in recent years, there remains a significant proportion of patients who do not yet derive benefit from available treatments. Immunotherapies currently licensed for clinical use target the adaptive immune system, focussing on Tcell interactions and functions. However, the most prevalent immune cells within the tumor microenvironment (TME) of melanoma are macrophages, a diverse immune cell subset displaying high plasticity, to which no… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
references
References 157 publications
0
0
0
Order By: Relevance